Current and future treatment of amyloid diseases

There are more than 30 human proteins whose aggregation appears to cause degenerative maladies referred to as amyloid diseases or amyloidoses. These disorders are named after the characteristic cross‐β‐sheet amyloid fibrils that accumulate systemically or are localized to specific organs. In most ca...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of internal medicine 2016-08, Vol.280 (2), p.177-202
Hauptverfasser:	Ankarcrona, M., Winblad, B., Monteiro, C., Fearns, C., Powers, E. T., Johansson, J., Westermark, G. T., Presto, J., Ericzon, B.‐G., Kelly, J. W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - therapy Alzheimer's disease Amyloid - physiology amyloidosis Amyloidosis - physiopathology Amyloidosis - therapy Animals Diabetes Mellitus, Type 2 - therapy Humans Liver Transplantation Prealbumin - physiology transthyretin treatment type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!